新型冠状病毒感染对哮喘儿童肺功能影响

doi:10.12372/jcp.2022.23e0163

Abstract

Abstract:

The pandemic of COVID-19 raises new challenges in the management of pediatric asthma. We analyzed airway injury in children with asthma from molecular mechanism to pathological alterations and explored the effect of SARS-CoV-2 on pulmonary function, which will inform clinicians in the diagnosis and management of childhood asthma in the context of the new coronavirus epidemic.

Key words: respiratory virus, SARS-CoV-2, lung function, bronchial asthma, child

WANG Jinrong, MIAO Yu, MA Guangzeng, CAO Luofei. Effect of SARS-CoV-2 infection on pulmonary function in children with asthma[J].Journal of Clinical Pediatrics, 2023, 41(5): 333-338.

References 44

[1]	World Health Organization. WHO Coronavirus (COVID-19)[EB/OL]. [2022-02-25]. https://covid19.who.int.
[2]	No authors listed. The global asthma report 2022[J]. Int J Tuberc Lung Dis, 2022, 26(1): 1-104.
[3]	Campos C, Prokopich S, Loewen H, et al. Long-term effect of COVID-19 on lung imaging and function, cardiorespiratory symptoms, fatigue, exercise capacity, and functional capacity in children and adolescents: a systematic review and meta-analysis[J]. Healthcare (Basel), 2022, 10(12): 2492.
[4]	Seibold MA, Moore CM, Everman JL, et al. Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: a prospective surveillance study[J]. J Allergy Clin Immunol, 2022, 150(2): 302-311. doi: 10.1016/j.jaci.2022.05.014 pmid: 35660376
[5]	Kompaniyets L, Agathis NT, Nelson JM, et al. Underlying medical conditions associated with severe COVID-19 illness among children[J]. JAMA Netw Open, 2021, 4(6): e2111182. doi: 10.1001/jamanetworkopen.2021.11182
[6]	Shi T, Pan J, Katikireddi SV, et al. Risk of COVID-19 hospital admission among children aged 5-17 years with asthma in Scotland: a national incident cohort study[J]. Lancet Respir Med, 2022, 10: 191-198. doi: 10.1016/S2213-2600(21)00491-4
[7]	Chiang CY, Ellwood P, Ellwood E, et al. Infection with SARS-CoV-2 among children with asthma: evidence from Global Asthma Network[J]. Pediatr Allergy Immunol, 2022, 33(1): e13709.
[8]	Pivniouk V, Pivniouk O, DeVries A, et al. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression[J]. J Allergy Clin Immunol, 2022, 149(3): 923-933.. doi: 10.1016/j.jaci.2021.11.019
[9]	Tay MZ, Poh CM, Rénia L, et al. The trinity of COVID-19: immunity, inflammation and intervention[J]. Nat Rev Immunol, 2020, 20(6): 363-374. doi: 10.1038/s41577-020-0311-8 pmid: 32346093
[10]	Vora SM, Lieberman J, Wu H. Inflammasome activation at the crux of severe COVID-19[J]. Nat Rev Immunol, 2021, 21(11): 694-703. doi: 10.1038/s41577-021-00588-x pmid: 34373622
[11]	Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet (London, England), 2020, 395(10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5
[12]	Shoenfeld Y. Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning[J]. Autoimmun Rev, 2020, 19(6): 102538. doi: 10.1016/j.autrev.2020.102538
[13]	Zhao L, Zhang YP, Yang X, et al. Eosinopenia is associated with greater severity in patients with coronavirus disease 2019[J]. Allergy, 2021, 76: 562-564. doi: 10.1111/all.v76.2
[14]	Crook H, Raza S, Nowell J, et al. Long covid-mechanisms, risk factors, and management[J]. BMJ, 2021, 374: n1648.
[15]	Cui S, Chen S, Li X, et al. Prevalence of venous throm-boembolism in patients with severe novel coronavirus pneumonia[J]. J Thromb Haemost, 2020, 18(6): 1421-1424. doi: 10.1111/jth.14830
[16]	Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, et al. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis[J]. Pulmonology, 2021, 27: 328-337. doi: 10.1016/j.pulmoe.2020.10.013
[17]	Öztürk GK, Beken B, Doğan S, et al. Pulmonary function tests in the follow-up of children with COVID-19[J]. Eur J Pediatr, 2022, 181: 2839-2847. doi: 10.1007/s00431-022-04493-w pmid: 35522314
[18]	Soyak Aytekin E, Sahiner UM, Tuten Dal S, et al. Obesity is a risk factor for decrease in lung function after COVID-19 infection in children with asthma[J]. Pediatr Pulmonol, 2022, 57: 1668-1676. doi: 10.1002/ppul.v57.7
[19]	Choudhary S, Sharma K, Silakari O. The interplay between inflammatory pathways and COVID-19: a critical review on pathogenesis and therapeutic options[J]. Microb Pathog, 2021, 150: 104673. doi: 10.1016/j.micpath.2020.104673
[20]	D'Agnillo F, Walters KA, Xiao Y, et al. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19[J]. Sci Transl Med, 2021, 13: eabj7790. doi: 10.1126/scitranslmed.abj7790
[21]	Du X, Yang Y, Yang Mg et al. ITGB4 deficiency induces mucus hypersecretion by upregulating MUC5AC in RSV-infected airway epithelial cells[J]. Int J Biol Sci, 2022, 18: 349-359. doi: 10.7150/ijbs.66215 pmid: 34975337
[22]	Sajuthi SP, DeFord P, Li Y, et al. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium[J]. Nat Commun, 2020, 11(1): 5139. doi: 10.1038/s41467-020-18781-2 pmid: 33046696
[23]	Postma DS, Brightling C, Baldi S, et al. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study[J]. Lancet Respir Med, 2019, 7(5): 402-416. doi: 10.1016/S2213-2600(19)30049-9 pmid: 30876830
[24]	Ashkenazi-Hoffnung L, Shmueli E, Ehrlich S, et al. Long COVID in children: observations from a designated pediatric clinic[J]. Pediatr Infect Dis J, 2021, 40: e509-e511. doi: 10.1097/INF.0000000000003285 pmid: 34371507
[25]	Maniscalco M, Ambrosino P, Fuschillo S, et al. Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation[J]. Respir Med, 2021, 182: 106401. doi: 10.1016/j.rmed.2021.106401
[26]	Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome[J]. Lancet Respir Med, 2020, 8(4): 420-422. doi: 10.1016/S2213-2600(20)30076-X pmid: 32085846
[27]	国家儿童医学中心, 首都医科大学附属北京儿童医院新型冠状病毒感染重症救治专家组, 北京儿童新型冠状病毒感染医疗救治市级专家组. 儿童新型冠状病毒Omicron变异株感染重症早期识别和诊治建议[J]. 中华儿科杂志, 2023, 61(3): 199-202.
[28]	Faverio P, Luppi F, Rebora P, et al. Six-month pulmonary impairment after severe COVID-19: a prospective, multicentre follow-up study[J]. Respiration, 2021, 100: 1078-1087. doi: 10.1159/000518141
[29]	Xu C, Ma M, Yi Y, et al. Clinical features and high-resolution chest computerized tomography findings of children infected by the B.1.617.2 variant of coronavirus disease 2019[J]. Ann Med, 2022, 54(1): 2391-2401. doi: 10.1080/07853890.2022.2114608 pmid: 36039499
[30]	Long ME, Mallampalli RK, Horowitz JC. Pathogenesis of pneumonia and acute lung injury[J]. Clin Sci (Lond), 2022, 136(10): 747-769. doi: 10.1042/CS20210879 pmid: 35621124
[31]	Heiss R, Tan L, Schmidt S, et al. Pulmonary dysfunction after pediatric COVID-19[J]. Radiology, 2023, 306(3): e221250. doi: 10.1148/radiol.221250
[32]	Camporota L, Cronin JN, Busana M, et al. Pathophysiology of coronavirus-19 disease acute lung injury[J]. Curr Opin Crit Care e, 2022, 28(1): 9-16.
[33]	Xiao C, Puddicombe SM, Field S, et al. Defective epithelial barrier function in asthma[J]. J Allergy Clin Immunol, 2011, 128(3): 549-556. doi: 10.1016/j.jaci.2011.05.038 pmid: 21752437
[34]	Bajbouj K, Ramakrishnan RK, Hamid Q. Role of matrix metalloproteinases in angiogenesis and its implications in asthma[J]. J Immunol Res, 2021: 6645072.
[35]	Lee KS, Min KH, Kim SR, et al. Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma[J]. Am J Respir Crit Care Med, 2006, 174(2): 161-170. doi: 10.1164/rccm.200510-1558OC
[36]	Lucas C, Wong P, Klein J, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19[J]. Nature, 2020, 584(7821): 463-469. doi: 10.1038/s41586-020-2588-y
[37]	Pathinayake PS, Awatade NT, Wark PAB. Type 2 immunity and its impact on COVID-19 infection in the airways[J]. Viruses, 2023, 15(2): 402. doi: 10.3390/v15020402
[38]	Roberts LM, Jessop F, Wehrly TD, et al. CuttinG EDGE: LUNG-RESident T cells elicited by SARS-CoV-2 do not mediate protection against secondary infection[J]. J Immunol, 2021, 207(10): 2399-404. doi: 10.4049/jimmunol.2100608 pmid: 34607940
[39]	Rahimi RA, Nepal K, Cetinbas M, et al. Distinct functions of tissue-resident and circulating memory Th2 cells in allergic airway disease[J]. J Exp Med, 2020, 217(9) : e20190865.
[40]	May BC, Gallivan KH. Levocetirizine and montelukast in the COVID-19 treatment paradigm[J]. Int Immu-nopharmacol, 2022, 103: 108412.
[41]	Mera-Cordero F, Bonet-Monne S, Almeda-Ortega J, et al. Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol[J]. Trials, 2022, 23(1): 19. doi: 10.1186/s13063-021-05951-w pmid: 34991703
[42]	Zhang L, Wang X, Huang Y, et al. Pediatric asthma situation in Chengdu, China, during the COVID-19 pandemic: an observational study[J]. J Asthma Allergy, 2021, 14: 829-838. doi: 10.2147/JAA.S315695 pmid: 34276218
[43]	Borg Bm, Osadnik C, Adam K, et al. Pulmonary function testing during SARS-CoV-2: An ANZSRS/TSANZ position statement[J]. Respirology, 2022, 27(9): 688-719. doi: 10.1111/resp.14340 pmid: 35981737
[44]	Franczuk M, Przybyłowski T, Czajkowska-Malinowska M, et al. Spirometry during the SARS-CoV-2 pandemic. Guidelines and practical advice from the expert panel of Respiratory Physiopathology Assembly of Polish Respiratory Society[J]. Adv Respir Med, 2020, 88(6): 640-650. doi: 10.5603/ARM.a2020.0186 pmid: 33393664

Effect of SARS-CoV-2 infection on pulmonary function in children with asthma

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References 44

Related Articles 15

Metrics

Comments

Recommended 0

[1]	LIN Jinfeng, CHEN Yi, DENG Yan, FENG Ai, HUANG Juan, CHEN Lizhu, XIE Jingqi, NIE Xiaojing. A comparative study on the detection of anti-Nephrin antibodies in children's nephrotic syndrome by chemiluminescence method and cell-based assay [J]. Journal of Clinical Pediatrics, 2026, 44(8): 682-689.
[2]	ZHENG Fangyuan, WANG Miao, DING Mingming, LU Aidong, JIA Yueping, ZENG Huimin, ZHANG Leping. Next-generation sequencing identified gene variants and their prognostic impact in pediatric Philadelphia chromosome positive acute lymphoblastic leukemia [J]. Journal of Clinical Pediatrics, 2026, 44(8): 690-697.
[3]	ZHANG Xiao, FANG Hongjun, KUANG Xiaojun, WANG Lijuan, WU Zhao, JIANG Sha, LI Pei, WU Liwen. Analysis of the clinical and electrophysiological characteristics of atonic seizures in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 698-704.
[4]	WANG Mengqian, YANG Hui. Case series analysis of 13 intestinal Behcet’s syndrome in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 705-711.
[5]	WU Xirong, GAO Qi, GUO Siyuan, YIN Qingqin, QIN Qiang, YIN Ju, JIAO Anxia, CHEN Chenghao, WU Di, WANG Bei, DUAN Xiaomin, PENG Yun, XU Baoping, GAO Liwei. Clinical characteristics and prognosis of pulmonary mucormycosis in children with diabetes mellitus [J]. Journal of Clinical Pediatrics, 2026, 44(8): 712-720.
[6]	HAN Yanan, GE Lanlan, CUI Jieyuan. A case report of branchio-oto-renal syndrome caused by EYA1 gene variant with a 6-year follow-up [J]. Journal of Clinical Pediatrics, 2026, 44(8): 721-726.
[7]	SHI Jiayi, GAO Chunlin, JIA Lili, LU Yunyun, SUN Tao, ZHU Xiaodong, XIA Zhengkun, ZHANG Pei. Phenotypic characteristics and prognostic analysis of a pedigree with childhood isolated nephrotic syndrome caused by compound heterozygous mutations in the COQ2 gene [J]. Journal of Clinical Pediatrics, 2026, 44(8): 727-732.
[8]	Rachel Rosen, Osvaldo Borrelli, Christophe Faure, Katja Karrento, Usha Krishnan, Samuel Nurko, Nathalie Rommel, Alan Silverman, Michiel van Wijk, Marc Benninga (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: upper gastrointestinal disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 595-608.
[9]	Carlo Di Lorenzo, Miguel Saps, Bruno P. Chumpitazi, Shaman Rajindrajith, Annamaria Staiano, Nikhil Thapar, Miranda van Tilburg, Carlos Velasco-Benítez, Arine Vlieger (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: lower and biliary disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 609-621.
[10]	LI Xufeng, TANG Haoxun, LI Xingjun, ZHANG Lize, GAO Chenqing, ZHAO Shunying, LIU Jianhua. Clinical characteristics, chest CT imaging phenotypes, and their correlation with prognosis in 76 children with Chlamydia pneumoniae pneumonia [J]. Journal of Clinical Pediatrics, 2026, 44(7): 622-627.
[11]	WANG Zhen, SHAO Jingbo, ZHANG Na, XIA Min, ZHU Jiashi, DU Chengkan, LI Hong. Factors influencing long-term recurrence in pediatric acute lymphoblastic leukemia patients with low-risk disease at initial diagnosis: a five-year follow-up analysis of 254 cases from a single center [J]. Journal of Clinical Pediatrics, 2026, 44(7): 628-635.
[12]	GUO Xuemei, XUE Yao, WANG Yongren, RONG Liucheng, FANG Yongjun, LIN Rufeng. Clinical features and prognosis of childhood acute myeloid leukemia with CBFA2T3::GLIS2 fusion [J]. Journal of Clinical Pediatrics, 2026, 44(7): 636-643.
[13]	YANG Lijun, FU Dongxia, CUI Yan, YANG Junmei, ZHANG Liming. Clinical manifestation and genetic analysis of CHARGE syndrome caused by CHD7 gene variation [J]. Journal of Clinical Pediatrics, 2026, 44(7): 644-650.
[14]	HU Yan, YANG Fan, LIANG Aimin, MAO Meng. Identification and management of faltering growth in children: insights from the 13th International Conference on Nutrition and Growth [J]. Journal of Clinical Pediatrics, 2026, 44(6): 485-488.
[15]	LIU Ziyao, WANG Congying, WANG Hongmao, ZHANG Mingming, XU Yingjie, LAI Jianming, NIU Wenquan, LI Xiaohui. Early differentiation of Kawasaki disease with joint symptoms and systemic juvenile idiopathic arthritis with Kawasaki disease-like symptoms: a single-center retrospective study [J]. Journal of Clinical Pediatrics, 2026, 44(6): 489-498.